Insider Shareholders with Direct Ownership of Madrigal Pharmaceuticals, Inc. (MDGL)
This section provides a comprehensive overview of the insiders with direct ownership of Madrigal Pharmaceuticals, Inc. (MDGL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
MADRIGAL PHARMACEUTICALS, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Rebecca Taub
Pres., R&D, and CMO |
102,351 | 78,110 | 458,999 $125 Million | 11 |
Apr 08, 2024
Reduced 0.04%
|
24,401 | 61,489 | 375,076 $102 Million | 5 |
Jun 25, 2024
Added 0.19%
|
|
127,382 | 102,254 | 186,449 $50.7 Million | 11 |
Jun 25, 2024
Added 0.38%
|
|
William John Sibold
President and CEO |
62,250 | 0 | 62,250 $16.9 Million | 2 |
Jan 23, 2024
Added 16.44%
|
Alex G. Howarth
Chief Financial Officer |
19,804 | 1,067 | 18,737 $5.09 Million | 3 |
Jan 23, 2024
Added 20.4%
|
Brian Joseph Lynch
SVP and General Counsel |
48,440 | 30,749 | 17,691 $4.81 Million | 15 |
Jan 23, 2024
Added 17.06%
|
Remy Sukhija
Chief Commercial Officer |
45,001 | 30,000 | 15,001 $4.08 Million | 3 |
Jan 16, 2023
Added 50.0%
|
Carole Huntsman
Chief Commercial Officer |
11,473 | 0 | 11,473 $3.12 Million | 2 |
Jan 23, 2024
Added 24.08%
|
35,401 | 33,489 | 11,012 $2.99 Million | 6 |
Jun 25, 2024
Added 6.09%
|
|
Robert E. Waltermire
Senior VP, Chief Pharma Dev. |
28,786 | 23,286 | 5,500 $1.49 Million | 20 |
Jun 14, 2024
Reduced 25.68%
|
34,401 | 32,489 | 1,912 $519,433 | 6 |
Jun 25, 2024
Added 27.19%
|
|
34,401 | 32,489 | 1,912 $519,433 | 6 |
Jun 25, 2024
Added 27.19%
|
|
Bay City Capital Llc
> 10% Shareholder |
0 | 24,172 | 1,261 $342,575 | 1 |
Dec 03, 2021
Reduced 95.04%
|